Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 23313007)

1.

Temporal trends in medication use and outcomes in atrial fibrillation.

Pilote L, Eisenberg MJ, Essebag V, Tu JV, Humphries KH, Leung Yinko SS, Behlouli H, Guo H, Jackevicius CA.

Can J Cardiol. 2013 Oct;29(10):1241-8. doi: 10.1016/j.cjca.2012.09.021. Epub 2013 Jan 8.

PMID:
23313007
2.

Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation.

Ionescu-Ittu R, Abrahamowicz M, Jackevicius CA, Essebag V, Eisenberg MJ, Wynant W, Richard H, Pilote L.

Arch Intern Med. 2012 Jul 9;172(13):997-1004. doi: 10.1001/archinternmed.2012.2266. Erratum in: Arch Intern Med. 2012 Jul 23;172(14):1085.

PMID:
22664954
3.

Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M; AFFIRM Investigators.

Am Heart J. 2005 Apr;149(4):650-6.

PMID:
15990748
4.

Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.

Kirchhof P, Breithardt G, Camm AJ, Crijns HJ, Kuck KH, Vardas P, Wegscheider K.

Am Heart J. 2013 Sep;166(3):442-8. doi: 10.1016/j.ahj.2013.05.015. Epub 2013 Jul 30.

5.

Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.

Agarwal S, Bennett D, Smith DJ.

Am J Cardiovasc Drugs. 2010;10(1):37-48. doi: 10.2165/11318870-000000000-00000.

PMID:
20104933
6.

Treatment of atrial fibrillation.

Bajpai A, Savelieva I, Camm AJ.

Br Med Bull. 2008;88(1):75-94. doi: 10.1093/bmb/ldn046. Epub 2008 Dec 5. Review.

PMID:
19059992
7.

Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.

Agarwal S, Hachamovitch R, Menon V.

Arch Intern Med. 2012 Apr 23;172(8):623-31; discussion 631-3. doi: 10.1001/archinternmed.2012.121. Epub 2012 Mar 26. Review.

PMID:
22450212
8.

Role of new drugs for management of atrial fibrillation.

Hollands JM, Gowan M, Riney JN, Deal EN, Kates AM.

Ann Pharmacother. 2012 Dec;46(12):1656-70. doi: 10.1345/aph.1R155. Epub 2012 Dec 18. Review.

PMID:
23249869
9.

Atrial fibrillation: pharmacological therapy.

Patel C, Salahuddin M, Jones A, Patel A, Yan GX, Kowey PR.

Curr Probl Cardiol. 2011 Mar;36(3):87-120. doi: 10.1016/j.cpcardiol.2011.01.001. Review.

PMID:
21392636
10.

Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.

Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.

Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002.

PMID:
19616184
11.

Risks and benefits of rate control versus maintenance of sinus rhythm.

Saxonhouse SJ, Curtis AB.

Am J Cardiol. 2003 Mar 20;91(6A):27D-32D. Review.

PMID:
12670639
12.

Effect of age on treatment, trends and outcome of patients hospitalized with atrial fibrillation: insights from a 20-years registry in a Middle-Eastern country (1991-2010).

Salam AM, AlBinali HA, Al-Sulaiti EM, Al-Mulla AW, Singh R, Al Suwaidi J.

Aging Clin Exp Res. 2012 Dec;24(6):682-90. doi: 10.3275/8757. Epub 2012 Nov 26.

PMID:
23211770
13.

Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.

Sherman DG, Kim SG, Boop BS, Corley SD, Dimarco JP, Hart RG, Haywood LJ, Hoyte K, Kaufman ES, Kim MH, Nasco E, Waldo AL; National Heart, Lung, and Blood Institute AFFIRM Investigators.

Arch Intern Med. 2005 May 23;165(10):1185-91.

PMID:
15911734
14.
15.

Resource utilization and outcomes in patients with atrial fibrillation: a case control study.

Boggon R, Lip GY, Gallagher AM, van Staa TP.

Appl Health Econ Health Policy. 2012 Jul 1;10(4):249-59. doi: 10.2165/11599940-000000000-00000.

PMID:
22540235
16.

Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study.

Turakhia MP, Hoang DD, Xu X, Frayne S, Schmitt S, Yang F, Phibbs CS, Than CT, Wang PJ, Heidenreich PA.

Am Heart J. 2013 Jan;165(1):93-101.e1. doi: 10.1016/j.ahj.2012.10.010. Epub 2012 Nov 20.

PMID:
23237139
17.

Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002).

Lakshminarayan K, Solid CA, Collins AJ, Anderson DC, Herzog CA.

Stroke. 2006 Aug;37(8):1969-74. Epub 2006 Jun 29.

18.

Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation.

Tsadok MA, Jackevicius CA, Essebag V, Eisenberg MJ, Rahme E, Humphries KH, Tu JV, Behlouli H, Pilote L.

Circulation. 2012 Dec 4;126(23):2680-7. doi: 10.1161/CIRCULATIONAHA.112.092494. Epub 2012 Nov 2.

19.

Stroke associated with atrial fibrillation--incidence and early outcomes in the north Dublin population stroke study.

Hannon N, Sheehan O, Kelly L, Marnane M, Merwick A, Moore A, Kyne L, Duggan J, Moroney J, McCormack PM, Daly L, Fitz-Simon N, Harris D, Horgan G, Williams EB, Furie KL, Kelly PJ.

Cerebrovasc Dis. 2010;29(1):43-9. doi: 10.1159/000255973. Epub 2009 Nov 5.

20.

Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation.

Allen LaPointe NM, Governale L, Watkins J, Mulgund J, Anstrom KJ.

Am Heart J. 2007 Nov;154(5):893-8. Epub 2007 Aug 20.

PMID:
17967595
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk